Ovarian Cancer

Research

Mayo Clinic researchers at all three campuses study ovarian cancer. As members of the national Gynecologic Oncology Group, Mayo Clinic doctors are dedicated to improving treatment of gynecologic cancers. Mayo Clinic's Ovarian Cancer Research Group is a multidisciplinary team of doctors and scientists working together within the Women's Cancer Program to develop better ways to diagnose and treat ovarian cancer.

Mayo Clinic research has contributed to advances in surgery for ovarian cancer, including surgical debulking (or cytoreduction) of tumors. In addition, research at Mayo Clinic helped create the current standard chemotherapy regimen, which combines the use of paclitaxel and carboplatin.

Mayo Clinic researchers are working to:

• Identify genetic factors that influence development of ovarian cancer and response to chemotherapy
• Identify mechanisms in the body related to treatment
• Develop attenuated measles virus as therapy for ovarian cancer
• Develop approaches to preventing or delaying ovarian cancer recurrence

Women's Cancer Program

Women's Cancer Program researchers work to improve treatment for women who have breast and gynecologic cancers. Researchers in gynecologic surgery, medical and radiation oncology, medical genetics, pathology and other specialties work together to give women who have cancer the widest possible range of treatment options. As part of the Mayo Clinic Cancer Center, the Women's Cancer Program offers the opportunity to participate in clinical trials of therapies in development. The Women's Cancer Program also provides social support classes, a resource center and education for women and their families.

Publications

See a list of publications by Mayo Clinic doctors on ovarian cancer on PubMed, a service of the National Library of Medicine.